Research ExplorerPublicationsBilateral renal vein thrombosis and venous sinus thrombosis ...

Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden)

Standard

Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden). / Pohl, M; Zimmerhackl, L B; Heinen, F; Sutor, A H; Schneppenheim, R; Brandis, M.

In: J PEDIATR-US, Vol. 132, No. 1, 01.01.1998, p. 159-61.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Pohl, M, Zimmerhackl, LB, Heinen, F, Sutor, AH, Schneppenheim, R & Brandis, M 1998, 'Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden)', J PEDIATR-US, vol. 132, no. 1, pp. 159-61.

APA

Pohl, M., Zimmerhackl, L. B., Heinen, F., Sutor, A. H., Schneppenheim, R., & Brandis, M. (1998). Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden). J PEDIATR-US, 132(1), 159-61.

Vancouver

Pohl M, Zimmerhackl LB, Heinen F, Sutor AH, Schneppenheim R, Brandis M. Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden). J PEDIATR-US. 1998 Jan 1;132(1):159-61.

Bibtex

@article{a97abc12eaa946ecbed2963a5b30754c,
title = "Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden)",
abstract = "Bilateral renal vein thrombosis and venous sinus thrombosis were diagnosed within 3 weeks of birth in a full-term neonate. Heterozygosity for a factor V mutation leading to resistance against the anticoagulatory properties of activated protein C was found. Heparin therapy led to resolution of the thrombotic manifestations. With long-term oral anticoagulation, no relapse or other thrombotic event occurred during infancy.",
keywords = "Anticoagulants, Blood Coagulation Disorders, Factor V, Heparin, Heterozygote, Humans, Infant, Newborn, Intracranial Embolism and Thrombosis, Male, Mutation, Renal Veins, Thrombosis",
author = "M Pohl and Zimmerhackl, {L B} and F Heinen and Sutor, {A H} and R Schneppenheim and M Brandis",
year = "1998",
month = jan,
day = "1",
language = "English",
volume = "132",
pages = "159--61",
journal = "J PEDIATR-US",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Bilateral renal vein thrombosis and venous sinus thrombosis in a neonate with factor V mutation (FV Leiden)

AU - Pohl, M

AU - Zimmerhackl, L B

AU - Heinen, F

AU - Sutor, A H

AU - Schneppenheim, R

AU - Brandis, M

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Bilateral renal vein thrombosis and venous sinus thrombosis were diagnosed within 3 weeks of birth in a full-term neonate. Heterozygosity for a factor V mutation leading to resistance against the anticoagulatory properties of activated protein C was found. Heparin therapy led to resolution of the thrombotic manifestations. With long-term oral anticoagulation, no relapse or other thrombotic event occurred during infancy.

AB - Bilateral renal vein thrombosis and venous sinus thrombosis were diagnosed within 3 weeks of birth in a full-term neonate. Heterozygosity for a factor V mutation leading to resistance against the anticoagulatory properties of activated protein C was found. Heparin therapy led to resolution of the thrombotic manifestations. With long-term oral anticoagulation, no relapse or other thrombotic event occurred during infancy.

KW - Anticoagulants

KW - Blood Coagulation Disorders

KW - Factor V

KW - Heparin

KW - Heterozygote

KW - Humans

KW - Infant, Newborn

KW - Intracranial Embolism and Thrombosis

KW - Male

KW - Mutation

KW - Renal Veins

KW - Thrombosis

M3 - SCORING: Journal article

C2 - 9470020

VL - 132

SP - 159

EP - 161

JO - J PEDIATR-US

JF - J PEDIATR-US

SN - 0022-3476

IS - 1

ER -